<； p >； The Invention relates to the field of Veterinary Medicine. The Composition of a Biological product is safe and effective, and the Application procedure, used in el u00a0tratamiento of Canine Distemper. The product of the invention is composed of immunoglobulin G fraction, Purified and specific reason to Distemper Virus from 60 to 120 u00a0 u00b5g / ml Physiological saline solution of 0.8 to 0.9 percent. In particular, the procedure for obtaining, immunoglobulins from Serum of the Target species, with high rate of Antibodies with an immunogen prepared dogs with Distemper Virus Lederle Strain. Species Specificity, in this sense, it is a distinguishing feature that gives the product of the invention.The survival and Recovery are 100 percent in the Group treated with the product, showing significant differences compared with the control Group. The Risk Analysis demonstrated the probability of survival and Recovery without sequelae if treated with the product of the invention.In addition, we determined the number of Animals needed to treat (NNT) that indicates the number of Animals to try to save or get sick, and is 2.3 times more likely to get a sick animal, whether it is the product of the invention if it is not treated. <； / p >；<；p>；La invención se relaciona al campo de la medicina veterinaria. Brinda la composición de un producto biológico seguro y eficaz, y el procedimiento para obtenerlo, empleado en el tratamiento de Moquillo canino. El producto de la invención está compuesto por inmunoglobulina, fracción G, purificada y específica a virus Distemper a razón de 60 a 120 µg/mL en solución salina fisiológica de 0.8 a 0.9 porciento. En el procedimiento de obtención, particularmente, las inmunoglobulinas proceden de sueros de la propia especie diana, perros hiperinmunizados con un inmunógeno preparado con virus Distemper, cepa Lederle. La especificidad de especie, en este sentido, es una característica distintiva que brinda el producto de invenci
